- Report
- September 2023
- 112 Pages
Europe
From €3013EUR$3,450USD£2,617GBP
- Report
- September 2023
- 194 Pages
Global
From €4323EUR$4,950USD£3,755GBP
- Report
- February 2024
- 93 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- November 2023
- 112 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Report
- November 2023
- 114 Pages
Global
From €3500EUR$4,293USD£3,147GBP
- Book
- October 2012
- 1570 Pages
The Rotavirus Vaccine is a vaccine used to protect against rotavirus infection, a common cause of severe diarrhea in infants and young children. It is administered orally, usually in two or three doses, depending on the brand. The vaccine is recommended for all infants in the United States, and is included in the routine childhood immunization schedule. It is also recommended in many other countries, including the United Kingdom, Canada, Australia, and many countries in Europe and Asia.
The Rotavirus Vaccine market is a growing segment of the Vaccines market, with a number of companies offering products. These companies include Merck, GlaxoSmithKline, Sanofi Pasteur, and Pfizer, among others. They offer a range of products, including monovalent and pentavalent vaccines, as well as combination vaccines. Show Less Read more